These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1712705)

  • 1. Current pharmacological treatment approaches to central nervous system leukaemia.
    Blaney SM; Balis FM; Poplack DG
    Drugs; 1991 May; 41(5):702-16. PubMed ID: 1712705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic approaches to the treatment of meningeal malignancy.
    Blaney SM; Balis FM; Poplack DG
    Oncology (Williston Park); 1991 May; 5(5):107-16; discussion 123, 127. PubMed ID: 1831994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system pharmacology of antileukemic drugs.
    Balis FM; Poplack DG
    Am J Pediatr Hematol Oncol; 1989; 11(1):74-86. PubMed ID: 2496615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
    Fleischhack G; Jaehde U; Bode U
    Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of intrathecal chemotherapy for human meningeal neoplasms.
    Bleyer WA
    Natl Cancer Inst Monogr; 1977 Dec; 46():171-8. PubMed ID: 580638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic strategies for the treatment of meningeal malignancy.
    Blaney SM; Poplack DG
    Invest New Drugs; 1996; 14(1):69-85. PubMed ID: 8880395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetaboliths in the prophylaxis and treatment of central nervous system leukemia.
    Haghbin M
    Cancer Treat Rep; 1977 Jul; 61(4):661-6. PubMed ID: 267507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of meningeal leukemia using systemic high-dose cytosine arabinoside.
    Frick J; Ritch PS; Hansen RM; Anderson T
    J Clin Oncol; 1984 May; 2(5):365-8. PubMed ID: 6726293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of leukemic infiltrations of the central nervous system. Preliminary communication].
    Swencz-Szczepanik K; Kołakowska-Polubiec K; Królikiewicz H; Kaczyńska D; Maj S; Pawelski S
    Acta Haematol Pol; 1978; 9(4):257-61. PubMed ID: 282763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of central nervous system leukemia in acute childhood leukemia. I. Results of intrathecal single or multiple drug combination therapy (author's transl)].
    Fujimoto T; Hasegawa K; Shin H; Kishida K; Take H
    Rinsho Ketsueki; 1975 Dec; 16(12):1109-16. PubMed ID: 1243683
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of meningeal leukemia.
    Pochedly C
    Hosp Pract; 1976 Nov; 11(11):123-8. PubMed ID: 1037446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
    Fujimoto T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
    Morra E; Lazzarino M; Alessandrino EP; Inverardi D; Regazzi Bonora M; Pagnucco G; Orlandi E; Bernasconi P; Canevari A; Rondanelli R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():101-3. PubMed ID: 2713552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone in the treatment of meningeal leukemia.
    Gómez-Almaguer D; González-Llano O; Montemayor J; Jaime-Pérez JC; Galindo C
    Am J Hematol; 1995 Aug; 49(4):353-4. PubMed ID: 7639283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
    Kwong YL; Yeung DY; Chan JC
    Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intraventricular chemotherapy for treatment of meningeal dissemination from malignant neoplasms (author's transl)].
    Yamada K; Ushio Y; Hayakawa T; Mogami H; Bremer AM; West CR
    No Shinkei Geka; 1980 May; 8(5):443-7. PubMed ID: 7383259
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the Ommaya reservoir in the prevention and treatment of CNS leukemia.
    Haghbin M; Galicich JH
    Am J Pediatr Hematol Oncol; 1979; 1(2):111-7. PubMed ID: 317416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.